Novartis | 판매 및 관리 비용

Selling And Administration Expenses 변화 날짜
AbbVie USD 3.32B 291M 2024-03
Amgen USD 1.81B 44M 2024-03
AstraZeneca USD 4.63B 100M 2024-03
Bausch Health Companies USD 794M 28M 2024-03
Biogen USD 581.5M 27M 2024-03
Bristol-Myers Squibb USD 2.37B 303M 2024-03
Canopy Growth CAD 41.28M 9.72M 2024-03
Catalent USD 214M 36M 2024-03
Corcept Therapeutics USD 56.27M 9.12M 2024-03
Drreddys Laboratories INR 18.43B 1.47B 2023-12
Eli Lilly USD 1.84B 88.5M 2024-03
Gilead Sciences USD 1.38B 233M 2024-03
GlaxoSmithKline GBP 2.09B 500M 2024-03
Glaxosmithkline GBP 2.09B 500M 2024-03
J&J USD 5.06B 753M 2024-03
Merck USD 2.48B 268M 2024-03
Novartis USD 2.84B 604M 2024-03
Novartis USD 2.84B 604M 2024-03
Pacira USD 72.03M 6.22M 2024-03
Perrigo USD 305.6M 1.2M 2024-03
Pfizer USD 3.5B 976M 2024-03
Prestige Brands USD 63.98M 1.49M 2024-03
Roche Holding CHF 6.51B 26M 2023-06
Sanofi EUR 2.6B 26M 2024-03
Sanofi EUR 2.6B 26M 2024-03
Supernus Pharmaceuticals USD 86.52M 5.23M 2024-03
Zoetis USD 547M 18M 2024-03



Novartis 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Jun 2024.